找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪(fǎng)問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Recent Advances in Therapeutic Drug Monitoring and Clinical Toxicology; Seth Kwabena Amponsah,Yashwant V. Pathak Book 2022 The Editor(s) (

[復(fù)制鏈接]
51#
發(fā)表于 2025-3-30 11:24:05 | 只看該作者
52#
發(fā)表于 2025-3-30 14:07:26 | 只看該作者
Analytical Techniques for Therapeutic Drug Monitoring and Clinical Toxicology, seamless workflow. This chapter, thus, discusses the various high-throughput analytical techniques employed in TDM and CT, as well as the challenges associated with their respective applications as reported in the literature. It must be emphasized that consideration for a suitable analytical method
53#
發(fā)表于 2025-3-30 20:29:29 | 只看該作者
Plasma Therapeutic Drug Monitoring and Clinical Toxicology,ell as age-related changes in drug metabolism, further complicates medication dosing. Therapeutic drug monitoring in the context of each patient serves to address these factors and requires collaboration between pharmacy, nursing, and medical teams.
54#
發(fā)表于 2025-3-30 23:58:20 | 只看該作者
Dried Blood Spots in Therapeutic Drug Monitoring and Toxicology,evoted to discussing the implications of blood hematocrit variations (known as the hematocrit factor) and ways to tackle or cope with this pitfall. Finally, this chapter delineates the procedural steps in DBS sampling, recent innovations in DBS sampling, and high-throughput application of same.
55#
發(fā)表于 2025-3-31 02:11:32 | 只看該作者
56#
發(fā)表于 2025-3-31 08:40:08 | 只看該作者
57#
發(fā)表于 2025-3-31 10:48:42 | 只看該作者
58#
發(fā)表于 2025-3-31 17:25:15 | 只看該作者
Reducing Toxicity in Critically Ill Patients by Using Therapeutic Drug Monitoring,inetic/pharmacodynamic (PK/PD) target selection, and dosage optimization procedures. The goal of this chapter is to examine available information on TDM practices for different drug classes and to illustrate how TDM might be useful in the reduction of toxicity in critically ill patients with serious
59#
發(fā)表于 2025-3-31 19:13:06 | 只看該作者
60#
發(fā)表于 2025-4-1 00:52:11 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-19 04:00
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
平武县| 抚州市| 广灵县| 茌平县| 乐陵市| 衡南县| 灵璧县| 手机| 城口县| 罗山县| 扶余县| 阿鲁科尔沁旗| 新沂市| 陈巴尔虎旗| 岳阳县| 无为县| 晴隆县| 宜黄县| 柞水县| 胶南市| 通化县| 翁源县| 安国市| 高密市| 钟祥市| 阳曲县| 随州市| 鹿泉市| 全椒县| 曲水县| 呼玛县| 和平县| 翁源县| 鄂州市| 崇左市| 凌云县| 福鼎市| 吴堡县| 呼和浩特市| 沽源县| 天水市|